Press Releases

12345678910
Billions in New Trains, Same Slow Route: Boeing Field Air Service SeaPort Airlines is Making New Amtrak Trains Obsolete
As Amtrak prepares to debut it’s new $8 billion Airo trainsets – SeaPort Airlines is offering an alternative that cuts the travel time by over half and requires no massive public investment of funds.
By SeaPort Airlines · Via Business Wire · September 25, 2026
RefinedScience Expands Deep, Multimodal Pancreatic Cancer Dataset
RefinedScience today announced a multi-institutional agreement that puts the Marsico Pancreatic Cancer Initiative on track to become the world’s largest multimodal single-cell pancreatic ductal adenocarcinoma (PDAC) dataset by the end of 2026, with contracted and partnered access to more than 2,000 consented pancreatic cancer samples from leading academic and industry sources. Pancreatic cancer is among the deadliest major cancers, in large part because the disease’s biology varies widely from patient to patient, a heterogeneity most datasets are too shallow to capture.
By RefinedScience · Via Business Wire · September 25, 2026
RXT DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Rackspace Technology, Inc. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action – RXT
NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · September 25, 2026
CDW Completes Acquisition of Lovelytics
CDW (Nasdaq: CDW), the strategic end-to-end technology partner that turns customer ambition into outcomes, today announced that it has completed its previously announced acquisition of Lovelytics, a leading data and AI services firm and a member of the Databricks Brickbuilder Partner Network. The acquisition expands CDW's Services & Solutions portfolio and will bring the Lovelytics capabilities to a broader set of customers.
By CDW Corporation · Via Business Wire · September 25, 2026
William B. Gilmore Releases What Is the Ideal Government Model?, a Forward-Looking Call for Accountable and Innovative Public Leadership
Via ACN Newswire · September 25, 2026
Women Leaders Association Adds Jenny Shufelt as Milwaukee Coaching Partner, Bringing a Coach for Accomplished Women Who Refuse to Trade Themselves for the Next Promotion
Via ACN Newswire · September 25, 2026
Women Leaders Association Adds Deborah Donenfeld as New York Coaching Partner, Bringing a Coach Who Specializes in Starting Over in Midlife
Via ACN Newswire · September 25, 2026
St-Georges Provides Fourth Bi-Weekly Update on Management Cease Trade Order
Montréal, September 25, 2026 – TheNewswire - St-Georges Eco-Mining Corp. (CSE: SX) (OTCQB: SXOOF) (FSE: 85G1) is issuing its fourth bi-weekly default status report in accordance with National Policy 12-203, Management Cease Trade Orders.
Via TheNewswire.com · September 25, 2026
Vital Infrastructure Property Trust Announces $300 Million Offering of 4.865% Series C Senior Unsecured Debentures and Early Redemption of Series H Convertible Debentures
Toronto, Ontario--(Newsfile Corp. - September 25, 2026) - Vital Infrastructure Property Trust (TSX: VITL.UN) ("Vital Infrastructure" or the "REIT") announced...
Via Newsfile · September 25, 2026
Southland Receives Notice of Noncompliance with NYSE American Continued Listing Standards
On September 23, 2026, Southland Holdings, Inc. (NYSE American: SLND and SLND WS) (the “Company”) received notification (the “Notice”) from NYSE Regulation of the NYSE American LLC (“NYSE American”) that the Company is no longer in compliance with NYSE American’s continued listing standards. Specifically, the Notice states that the Company is not in compliance with the continued listing standards set forth in Sections 1003(a)(i) and 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”). Section 1003(a)(i) requires a listed company to have stockholders’ equity of $2.0 million or more if the listed company has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years. Section 1003(a)(ii) requires a listed company to have stockholders’ equity of $4.0 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. The Company reported stockholders’ deficit of $248.2 million at June 30, 2026, and had reported net losses in its last three fiscal years. The Company is also not currently eligible for any exemption in Section 1003(a) of the Company Guide from the stockholders’ equity requirements.
By Southland Holdings, Inc. · Via Business Wire · September 25, 2026
Sydney Homeowners Urged to Check Their Roofs as NSW Storm Season Gets Underway
Via ACN Newswire · September 25, 2026
ASN Software Introduces New California CARS Act Dealer Updates
Via PRLog · September 25, 2026
Microbot Medical® Highlights Growth Strategy
User Survey Demonstrates High Satisfaction of the LIBERTY System
By Microbot Medical Inc. · Via GlobeNewswire · September 25, 2026
Florence 1 Schools Launches Community Impact Award, Honoring Help 4 Kids Florence as Inaugural Recipient
New district award spotlights community partnerships.
By Florence 1 Schools · Via ACCESS Newswire · September 25, 2026
Silgan to Release Third Quarter 2026 Earnings Results on October 29, 2026
Silgan Holdings Inc. (NYSE: SLGN), a leading supplier of sustainable rigid packaging solutions for the world's essential consumer goods products, will release its third quarter 2026 earnings results on Thursday, October 29, 2026, before the U.S. markets open. At 8:00 a.m. eastern time on that day, Silgan will hold a conference call to discuss the Company’s results and performance for this period.
By Silgan Holdings Inc. · Via Business Wire · September 25, 2026
The Fairholme Focused Income Fund Announces Dividend
On September 25, 2026, the Fairholme Focused Income Fund (“FOCIX” or the “Fund”) distributed an Ordinary Income dividend of $0.05297 per share to shareholders of record as of September 24, 2026. The Fund’s Net Asset Value (“NAV”) was reduced by the amount of the distribution.
By Fairholme Focused Income Fund · Via Business Wire · September 25, 2026
Veracyte Announces Eight Decipher-Focused Studies to Be Presented at ASTRO 2026
Six oral presentations and two posters will highlight Decipher’s prognostic and predictive value in identifying patients’ risk of progression and likelihood of benefiting from treatment intensification
By Veracyte, Inc. · Via GlobeNewswire · September 25, 2026
Designer Kennel Club Crosses 2,000 Registrations as Designer Dog Ownership Hits Record Highs
Via ACN Newswire · September 25, 2026
Brookfield Real Assets Income Fund Inc. Declares Q4 2026 Distribution Schedule
NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Brookfield Real Assets Income Fund Inc. (NYSE: RA) (the “Fund”) today announced that its Board of Directors (the “Board”) declared the Fund’s monthly distributions for October, November and December 2026.
Vivek Narayan Sharma: The Long Road to the Supreme Court Bar
Washington DC, USA - September 24, 2026 - Vivek Narayan Sharma’s legal career reflects a professional progression from Hindi-medium schooling and a science education to practice as an Advocate-on-Record before the Supreme Court of India. Enrolled with the Bar Council of Delhi in 1999, Sharma has since worked across litigation, arbitration, mediation, legal-services initiatives and legal writing.
Via AB Newswire · September 25, 2026
BrainWin Launches Gamified App Blocker That Lets iPhone Users Earn Screen Time Through Healthy Habits Tracker
Austin, Texas - 25 September, 2026 - BrainWin has launched a gamified app blocker for iPhone that turns access to social media and video apps into something the user has to earn. The app is available now on the App Store and is aimed at people who want to reduce doomscrolling without giving up their apps entirely. Instead of a simple on-off switch, BrainWin blocks apps such as TikTok, Instagram, YouTube and X, awards brain points for completing healthy tasks, and lets the user spend those points on a timed unlock window. When the points run out, the block returns automatically.
Via AB Newswire · September 25, 2026
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026
HILLSIDE, NJ / ACCESS Newswire / September 25, 2026 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2026.
By Integrated BioPharma, Inc. · Via ACCESS Newswire · September 25, 2026
ASTRO 2026 Presentations Demonstrate Role of Genetics in Predicting Adverse Events and Response From Radiation Treatment
MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced that research supporting its PROSTOX technology and the role of germline biomarkers in predicting treatment-related adverse events and response will be featured in five presentations and educational sessions at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, taking place September 26-30, 2026, in Boston, Mass.
By MiraDx · Via Business Wire · September 25, 2026
New Data Highlight Artera's MMAI Consistency Across Diverse Patient Populations at ASTRO 2026
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will be featured in new data presented at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting.
By Artera · Via Business Wire · September 25, 2026
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency
SAN DIEGO, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced that on September 21, 2026, the Company received a notice (the “Notice”) from the staff of NYSE American LLC (the "NYSE American") that the Company was not in compliance with the NYSE American's continued listing standards in Part 10, Section 1003(a)(ii)of the NYSE American Company Guide (the "Company Guide")requiring a company to have stockholders' equity of at least $4.0 million if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. The Notice also indicates that the Company is not currently eligible for any exemption in Section 1003(a) of the Company Guide (including the exemption provided for companies with total value of market capitalization exceeding $50 million among other things).
By Calidi Biotherapeutics, Inc · Via GlobeNewswire · September 25, 2026
FireResist Expands Certified Fire Rated Door, Window and Curtain Wall Systems for UK Commercial Developments
London, United Kingdom - 25 September, 2026 - FireResist, a manufacturer and installer of certified fire rated doors, windows and curtain walls, has announced an expanded range of passive fire protection systems for commercial, hospitality and large scale residential developments across the United Kingdom. The range is available now and covers fire doors rated from FD30 to FD120 together with glazed screens and curtain walling tested to EI120. It is aimed at contractors, developers and architects who need certified compartmentation on projects governed by UK Building Regulations and Approved Document B.
Via AB Newswire · September 25, 2026
WISeKey Announces Planned Effectiveness of Redomiciliation from Switzerland to the British Virgin Islands
Zug, Switzerland, September 25, 2026 – WISeKey International Holding Ltd (“WISeKey” or the “Company”) (SIX: WIHN; NASDAQ: WKEY) today announced that it expects the previously announced redomiciliation of WISeKey from Switzerland to the British Virgin Islands to become effective on October 2, 2026 (the “Redomiciliation”). The Redomiciliation is being implemented through the cross-border merger of WISeKey with and into its wholly owned British Virgin Islands subsidiary, WISeQey Corp. (formerly known as WISeKey International Corp., “WISeQey”), with WISeQey continuing as the surviving company (the “Merger”). The Merger and Redomiciliation are expected to become legally effective on October 2, 2026, following completion of the applicable registration procedures.
By Wisekey International Holding Ltd. · Via GlobeNewswire · September 25, 2026
Advocacy Unveils Promptless, Revolutionizing AI Litigation Platform by Putting Humans in Control
Advocacy, the first context-driven AI platform for litigation, today released Promptless, a major expansion of its matter-centric technology that delivers AI support to litigation teams proactively—without prompting—while also giving a new level of primacy to human judgment in an AI litigation platform.
By Advocacy · Via Business Wire · September 25, 2026
Securities Fraud Investigation Into Tigo Energy, Inc. (TYGO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Tigo Energy, Inc. (“Tigo” or the “Company”) (NASDAQ: TYGO) investors concerning the Company’s possible violations of the federal securities laws.
By Glancy Prongay Wolke & Rotter LLP, · Via Business Wire · September 25, 2026
Torras Properties Expands Marine Operations with Launch of St. Marys Marina
Team behind Brunswick Landing Marina to operate new downtown St. Marys waterfront destination, anticipated to open by November 1.
By Torras Properties, Inc. · Via ACCESS Newswire · September 25, 2026
NYSE to Commence Delisting Proceedings Against SilverBox Corp IV (SBXD)
The New York Stock Exchange LLC (“NYSE” or “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the three securities enumerated below (“Securities”) of SilverBox Corp IV (the “Company”) from the NYSE. Trading in the Company’s Securities will be suspended immediately.
By NYSE Regulation · Via Business Wire · September 25, 2026
Ifinatamab Deruxtecan Biologics License Application for Certain Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer Voluntarily Withdrawn
The Biologics License Application (BLA) seeking accelerated approval in the U.S. for Daiichi Sankyo (TSE: 4568) and Merck’s (NYSE: MRK), known as MSD outside of the United States and Canada, ifinatamab deruxtecan (I-DXd) for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy has been voluntarily withdrawn.
By Daiichi Sankyo · Via Business Wire · September 25, 2026
MVB Bank Announces Strategic Partnership With DingoBlu Financial
DingoBlu Financial, Inc., a financial technology company developing a mobile-first platform for personal financial products, today announced a strategic partnership with MVB Bank, Inc. The partnership represents an important milestone as DingoBlu prepares to introduce its platform and suite of financial products.
By MVB Bank, Inc. · Via Business Wire · September 25, 2026
The New York Times Company Declares Regular Quarterly Dividend
The New York Times Company’s Board of Directors today declared a regular quarterly dividend of $0.23 per share on the Company’s Class A and Class B common stock. The dividend is payable on October 22, 2026, to shareholders of record as of the close of business on October 7, 2026.
By The New York Times Company · Via Business Wire · September 25, 2026
BioAge Labs to Present at Upcoming Investor Conferences
EMERYVILLE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for cardiometabolic diseases by targeting the biology of human aging, today announced that the Company will participate in the following upcoming investor conferences:
By BioAge Labs, Inc. · Via GlobeNewswire · September 25, 2026
NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments
VANCOUVER, British Columbia, Sept. 25, 2026 (GLOBE NEWSWIRE) -- NervGen (NASDAQ: NGEN), a late-stage clinical biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions, today announced it will restate its audited annual financial statements for the year ended December 31, 2025, and its unaudited interim financial statements for the quarter ended June 30, 2026.
By NervGen Pharma Corp. · Via GlobeNewswire · September 25, 2026
Weatherford Announces Third-Quarter 2026 Conference Call
HOUSTON, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) will host a conference call on Wednesday, October 21, 2026 to discuss the Company’s results for the third quarter ended September 30, 2026.
By Weatherford International, LLC · Via GlobeNewswire · September 25, 2026
USA Air Management Marks 30 Years of Air Duct Cleaning in NJ Urges Homeowners to Schedule Dryer Vent Cleaning Before Heating Season
Via PRLog · September 25, 2026
HAFNIA LIMITED: Public Filing of Prospectus Supplement in Connection with the Offering
Reference is made to the stock exchange announcement published by Hafnia Limited ("Hafnia" or the "Company”, OSE: HAFNI, NYSE: HAFN) on 24 September 2026 regarding the successful completion and pricing of an offering of 35,488,875 ordinary shares in the Company, raising gross proceeds of the NOK equivalent of approximately USD 300 million (the “Offering”).
By Hafnia Limited · Via Business Wire · September 25, 2026
Lancaster Realtor Mary Sue Wolf Helps Homeowners Downsize With Custom Plans
Lancaster County Realtor Mary Sue Wolf has launched customized downsizing plans to help local homeowners transition into smaller homes smoothly. Her tailored services provide step-by-step guidance, decluttering resources, home preparation, and market expertise to help clients maximize equity and reduce moving stress.
Via Press Release Distribution Service · September 25, 2026
TNS to Tackle Cross-Channel Fraud and Customer Trust in Two Sessions at CFCA Fall Educational 2026
Communications fraud rarely stays in one lane. Bad actors move across voice, messaging, email, applications and social media – spoofing financial institutions’ phone numbers to impersonate them and defraud customers, and exploiting the fact that the intelligence needed to stop them is often scattered across platforms, companies, industries, countries and continents. The result is a widening trust gap where consumers have grown wary of even legitimate outreach from the businesses they rely on. That erosion of trust has consequences beyond the initial fraud attempt as customers may ignore legitimate fraud alerts, account-security notifications, payment reminders, and other time-sensitive communications.
By Transaction Network Services · Via Business Wire · September 25, 2026
Citizens Against Government Waste Names Senator Bernie Sanders its September 2026 Porker of the Month
Today, Citizens Against Government Waste (CAGW) named Sen. Bernie Sanders (I-Vt.) its September 2026 Porker of the Month for introducing legislation that would ban superintelligence and freeze all other American artificial intelligence development until a new federal agency is created to control every aspect of the industry.
By Citizens Against Government Waste · Via Business Wire · September 25, 2026
The Coca-Cola Company Names Rob Gehring President of North America Operating Unit
The Coca-Cola Company today announced that Rob Gehring will become president of the company’s North America operating unit effective Dec. 1, 2026. Gehring succeeds John Murphy, who has led the North America operating unit on an interim basis since Aug. 1, 2026. Murphy remains president and chief financial officer.
By The Coca-Cola Company · Via Business Wire · September 25, 2026
Ventas Announces Third Quarter 2026 Earnings Release Date and Conference Call
Ventas, Inc. (NYSE: VTR) will issue its third quarter 2026 earnings release after the close of trading on the New York Stock Exchange on Tuesday, October 27, 2026. A conference call to discuss those earnings will be held on Wednesday, October 28, 2026 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time).
By Ventas, Inc. · Via Business Wire · September 25, 2026
KKR Announces Intra-Quarter Monetization Activity Update for the Third Quarter
KKR today announced income from monetization activity in excess of $750 million with respect to the period from July 1, 2026 through September 25, 2026 based on information currently available. The quarter-to-date monetization activity is made up of approximately 80% realized performance income and approximately 20% realized investment income. The quarter-to-date monetization activity is driven by a combination of public secondary sales and strategic transactions, as well as dividends and interest income.
By KKR · Via Business Wire · September 25, 2026
RiverNorth Opportunities Fund, Inc. Announces Final Results of Rights Offering
RiverNorth Opportunities Fund, Inc. (the “Fund”) (NYSE: RIV) today announced the final results of its transferable rights offering (the “Offering”). The Fund will issue a total of 3,356,796 new shares of common stock as a result of the Offering, which closed on September 23, 2026 (the “Expiration Date”).
By RiverNorth Opportunities Fund, Inc. · Via Business Wire · September 25, 2026
Deadline Soon: Doximity, Inc. (DOCS) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz reminds investors of the upcoming November 16, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) securities between August 8, 2024 and May 13, 2026, inclusive (the “Class Period”).
By The Law Offices of Frank R. Cruz · Via Business Wire · September 25, 2026
Crescent Biopharma Announces Grants of Inducement Awards
WALTHAM, Mass., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 31,200 shares of the Company’s ordinary shares to two non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the “Inducement Plan”). The options were approved on September 24, 2026 and were material to each employee's acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4).
By Crescent Biopharma, Inc. · Via GlobeNewswire · September 25, 2026
Reminder: HHH 2026 Annual Shareholder Meeting Set for September 30
Meeting to begin at 9 a.m. ET at 787 Seventh Avenue in New York City
By Howard Hughes Holdings Inc. · Via GlobeNewswire · September 25, 2026
Dr. Jay Johannigman Returns to Cincinnati Following 46 Years of Military Service
Via PRLog · September 25, 2026